Life Sciences

The many storylines about the Identification of Medicinal Products

The life science industry moves towards implementation of Identification of Medicinal Products (IDMP). However, the storylines about IDMP and the agenda of Drug Information Association (DIA) congresses are variegated.

How attractive are European Life Sciences Sites?

KPMG’s newest report on leading Life Sciences Clusters in Europe, released on 3 November 2015 at the Bio Europe Congress, reveals important differences between different countries in Europe and their attractiveness for Foreign Direct Investments for the Life Sciences Industry.

Swiss Stock Exchange attractive for Indian Life Sciences Companies

Switzerland is a favorite for globally leading life sciences companies. This, as well as its ranking as a global financial center is mirrored in the fact that the SIX Swiss Exchange in Zurich and its little cousin, the BX Berne eXchange, are attractive for listings of companies from the life sciences and high-tech industries from everywhere in the world.

Life Sciences Clusters in Europe

What makes a European Life Science site attractive to foreign investors? KPMG Switzerland’s Global Location Evaluation Services collaborated with Venture Valuation, a business intelligence boutique specializing in Life Sciences (LS), to analyze previously unpublished data comparing leading European LS clusters.